Forecasting The Future: 4 Analyst Projections For Cue Biopharma
Forecasting The Future: 4 Analyst Projections For Cue Biopharma
預測未來：分析師對Cue Biopharma的4項預測
Throughout the last three months, 4 analysts have evaluated Cue Biopharma (NASDAQ:CUE), offering a diverse set of opinions from bullish to bearish.
在過去的三個月中，有4位分析師對Cue Biopharma（納斯達克股票代碼：CUE）進行了評估，提供了從看漲到看跌的不同觀點。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
下表彙總了他們最近的評級，闡明瞭過去30天內情緒的變化，並將其與前幾個月進行了比較。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $8.0, a high estimate of $10.00, and a low estimate of $6.00. This current average has decreased by 7.73% from the previous average price target of $8.67.
分析師分析的12個月目標股價提供了見解，平均目標價爲8.0美元，最高估計爲10.00美元，低估值爲6.00美元。目前的平均價格較之前的平均目標價8.67美元下降了7.73％。
Investigating Analyst Ratings: An Elaborate Study
調查分析師評級：一項詳盡的研究
A comprehensive examination of how financial experts perceive Cue Biopharma is derived...
對金融專家如何看待Cue...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。